Lactobacillus plantarum against Helicobacter pylori infection, and use thereof
AssigneeWecare Probiotics Co., Ltd.
InventorsShuguang Fang, Zhonghui Gai, Yao Dong, Junli Zhang, Jiayue Gu, Jianguo Zhu
Life of this patent
Estimating the term…
Loading patent…
AssigneeWecare Probiotics Co., Ltd.
InventorsShuguang Fang, Zhonghui Gai, Yao Dong, Junli Zhang, Jiayue Gu, Jianguo Zhu
Estimating the term…
Provided are a Lactobacillus plantarum against Helicobacter pylori infection and the use thereof. The Lactobacillus plantarum against Helicobacter pylori infection is named Lactobacillus plantarum Lp05 and was deposited in the China General Microbiological Culture Collection Center on 9 Oct. 2021, with the deposit number CGMCC No. 23547. Further provided are a method for culturing the Lactobacillus plantarum against Helicobacter pylori infection and a product for inhibiting Helicobacter pylori infection. The Lactobacillus plantarum against Helicobacter pylori infection of the present application has good gastric acid resistance, inhibits the proliferation of Helicobacter pylori, and reduces the adhesion effect of Helicobacter pylori to gastric epithelial cells, thereby creating conditions for the eradication of Helicobacter pylori. The product for inhibiting Helicobacter pylori infection does not cause adverse reactions nor drug resistance of pathogenic bacteria.
A method for culturing a Lactobacillus plantarum against Helicobacter pylori infection, comprising:
A Helicobacter pylori inhibitor, comprising a Lactobacillus plantarum against Helicobacter pylori infection, which is named Lactobacillus plantarum Lp05 and deposited in the China General Microbiological Culture Collection Center on Oct. 9, 2021, with a deposit number CGMCC No. 23547,
A method for inhibiting Helicobacter pylori infection, comprising administering an effective amount of a product containing the Lactobacillus plantarum against Helicobacter pylori infection to subject in need thereof,
Dependencies are inferred from the claim text.